West Pharmaceutical Services (WST) Non-Current Assets (2009 - 2026)
West Pharmaceutical Services (WST) posted Non-Current Assets of $2.3 billion for Q2 2026, down 0.62% sequentially from $2.3 billion in Q1 2026, and little changed YoY from $2.3 billion in Q2 2025.
West Pharmaceutical Services (WST) Non-Current Assets (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Non-Current Assets for 18 years, with the latest figure at $2.3 billion in Q2 2026.
- Quarterly Non-Current Assets changed 0.13% year-over-year to $2.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.1 billion (up 5.35% YoY) and the FY2025 annual result came in at $2.3 billion, up 8.86% from the prior year.
- Non-Current Assets retreated to $2.3 billion in Q2 2026 per WST's latest filing, from $2.3 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $2.3 billion in Q4 2025 and troughed at $1.6 billion in Q3 2022.
- A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets rose 19.19% in 2024, then slipped 0.13% in 2026.
- Over 5 years, Non-Current Assets stood at $1.7 billion in 2022, then grew by 11.54% to $1.9 billion in 2023, then grew by 11.21% to $2.1 billion in 2024, then grew by 8.86% to $2.3 billion in 2025, then decreased by 1.0% to $2.3 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $2.3 billion, $2.3 billion, and $2.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.86 Bn | 129.64 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.40 Bn | 51.53 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 28.85 Bn | 26.17 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.35 Bn | 14.94 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 3.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Bn |
| Mar 31, 2026 | 2.28 Bn |
| Dec 31, 2025 | 2.29 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.27 Bn |
| Mar 31, 2025 | 2.16 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 2.12 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 1.89 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 1.80 Bn |
| Mar 31, 2023 | 1.79 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.59 Bn |
| Mar 31, 2022 | 1.60 Bn |
| Dec 31, 2021 | 1.57 Bn |
| Sep 30, 2021 | 1.54 Bn |